Zobrazeno 1 - 10
of 53
pro vyhledávání: '"Faraz Khan Luni"'
Autor:
Salik Nazir, Saroj Lohani, Niranjan Tachamo, Muhammad Sohail Khan, Bidhya Timilsina, Faraz Khan Luni, Anthony Donato
Publikováno v:
Journal of Cardiovascular and Thoracic Research, Vol 10, Iss 4, Pp 182-186 (2018)
Introduction: Transcatheter mitral valve-in-valve (ViV) & valve-in-ring (ViR) are relatively novel therapeutic alternatives for patients with degenerated bioprostheses or failed annuloplasty rings whose reoperative risk is too high. The predominant p
Externí odkaz:
https://doaj.org/article/f3b91be2f8a946b496cf078b3049df55
Autor:
Sonia Ali Malik, Jose A. Joglar, Neeraj Kaplish, James D. Daniels, Richard Wu, Mark S. Link, Faraz Khan Luni, Nath Zungsontiporn
Publikováno v:
The American Journal of Cardiology. 125:1738-1744
Transvenous neurostimulation of the phrenic nerve (PNS) is a potentially improved and unique approach to the treatment of central sleep apnea (CSA). There have been multiple studies with limited individuals evaluating the efficacy of PNS. Our aim was
Autor:
Sobia Khan, Jose A. Joglar, Richard Wu, Faraz Khan Luni, Sonia Ali Malik, Nath Zungsontiporn, Talha Farid, Mark S. Link, James D. Daniels
Publikováno v:
Journal of Cardiovascular Electrophysiology. 30:886-895
Introduction Catheter ablation of ventricular tachycardia (VT) can be an effective therapy to reduce VT burden, but often it is limited by the potential for hemodynamic instability. Percutaneous left ventricular assist devices (pLVADs) have been used
Autor:
Long Pham, Mohammed Ruzieh, Talha Farid, Haris Riaz, Aref A. Bin Abdulhak, Glenn A. Hirsch, Abdur Rahman Khan, Faraz Khan Luni, Roberto Bolli
Publikováno v:
American Journal of Therapeutics. 26:e151-e160
Background The safety and efficacy of supplemental oxygen in acute myocardial infarction (AMI) remains unclear. Study question To evaluate the safety and efficacy of supplemental oxygen in patients who present with AMI. Data sources We systematically
Autor:
Saroj Lohani, Anthony A. Donato, Bidhya Timilsina, Faraz Khan Luni, Muhammad S. Khan, Salik Nazir, Niranjan Tachamo
Publikováno v:
Journal of Cardiovascular and Thoracic Research, Vol 10, Iss 4, Pp 182-186 (2018)
Journal of Cardiovascular and Thoracic Research
Journal of Cardiovascular and Thoracic Research
Introduction: Transcatheter mitral valve-in-valve (ViV) & valve-in-ring (ViR) are relatively novel therapeutic alternatives for patients with degenerated bioprostheses or failed annuloplasty rings whose reoperative risk is too high. The predominant p
Autor:
Muhammad Imran Khan, Firas Ahmed Adeel, Faraz Khan Luni, Abdur Rahman Khan, Deepak Malhotra, Joan Duggan
Publikováno v:
Journal of Medical Cases. 9:289-292
Autor:
Douglas J. Federman, Sonia Ali Malik, Sadik A. Khuder, Faraz Khan Luni, Haris Riaz, Yusuf Kanjwal, Abdur Rahman Khan, Hemindermeet Singh, Ameer Kabour, Osama Dasa
Publikováno v:
The American Journal of the Medical Sciences. 354:395-398
Background Ischemic heart disease (IHD) has emerged as a major cause of morbidity and mortality in patients with autoimmune conditions such as systemic lupus erythematosus and rheumatoid arthritis, but the risk of IHD in Sjogren’s syndrome (SjS) is
Autor:
Ameer Kabour, Owais Khawaja, Johan D. Aasbo, Faraz Khan Luni, Sonia Ali Malik, Wade M. Lee, Mark Richards, Hemindermeet Singh, Haris Riaz, Abdur Rahman Khan
Publikováno v:
Journal of Cardiovascular Electrophysiology. 28:538-543
ICD in Nonischemic CardiomyopathyIntroduction Implantation of an implantable cardioverter defibrillator (ICD) for primary prevention of sudden cardiac death (SCD) is controversial in view of the recent DANISH trial which suggested no benefit with ICD
Publikováno v:
Journal of cardiovascular electrophysiology. 30(10)
Autor:
Muhammad Shahzeb Khan, Mohammed Taleb, Yusuf Kanjwal, Talha Riaz, Faraz Khan Luni, Haris Riaz, Irbaz Bin Riaz, Muhammad Husnain, Sadik A. Khuder, Christopher J. Cooper, Abdur Rahman Khan
Publikováno v:
Catheterization and Cardiovascular Interventions. 89:1168-1175
Background: Postoperative state is characterized by increased thrombotic risk by virtue of platelet activation. Whether aspirin ameliorates this risk in patients with established coronary artery disease undergoing cardiac or noncardiac surgery is unk